MedTrace Logo

Development of CV Risk Prediction Tools Based on AI and Fundus Imaging Technology Study (PERFECT)

NCT06181552 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1072

Last updated 2023-12-26

No results posted yet for this study

Summary

This study aims to develop a cardiovascular disease (CVD) screening tool and cardiovascular risk prediction tool based on fundus imaging data with the method of artificial intelligence.

Conditions

Interventions

DIAGNOSTIC_TEST

fundus photograpgy

All the participants will undergo fundus photography.

DIAGNOSTIC_TEST

optical coherence tomography

All the participants will undergo OCT examination.

DIAGNOSTIC_TEST

optical coherence tomography angiography

All the participants will undergo OCT-A examination.

Sponsors & Collaborators

  • Beijing Tongren Hospital

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Jing Li, PhD, MD · National Center for Cardiovascular Diseases, Fuwai Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2025-03-31
Completion
2025-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06181552 on ClinicalTrials.gov